학술논문

ET140202 T-cell therapy for the treatment of liver cancer is built upon a novel antibody-T cell receptor (AbTCR) ARTEMIS (TM) T-cell platform
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 6 2019, 7 1p. Supplement: 1
Subject
Language
English
ISSN
20511426